Sativa Group joins the ACI toxicology study

Cannabidiol (CBD), a key compound in cannabis, increases cerebral blood flow (CBF) in regions of the brain linked to memory processing, suggests a recent study in the Journal of Psychopharmacology. The results suggest the potential use

Sativa Group plc (AQUIS:SATI) has announced that the Special Meeting held by Stillcanna Inc. on Thursday August 27, approved the acquisition of Sativa Group PLC through ordinary resolution which  was duly passed with over 99.9% of

Cannabidiol (CBD) improves brain blood flow which could help improve memory, researchers have said. The team from the University of College London (UCL) say these findings could potentially contribute to better treatments for conditions like Alzheimer’s disease

There are numerous incredible innovations scientists and researchers have made in biotechnology in recent years. Among the fields of study are gene editing, tissue engineering and regeneration, nanobiotechnology and many others. In addition, new segments under

With the legalization of marijuana, people are turning towards it as a treatment for various ailments that they are suffering from in life. Cannabidiol oil or CBD is a byproduct of marijuana and is also gaining

Sativa Group Plc (AQSE:SATI) and Stillcanna Inc announced that they had agreed the terms of a recommended all-share acquisition of the entire issued and to be issued ordinary share capital of Sativa by Stillcanna. The Acquisition

Just one dose of cannabidoil (CBD) was shown to improve blood flow to parts of the brain, a new small study suggests. Researchers found that the main non-psychoactive ingredient in marijuana increased blood flow to the

Sativa Group Plc [AQSE:SATI], the UK’s leading quoted CBD wellness and medicinal cannabis company, has recorded a record month of revenues for the Group in July. We are pleased to announce that our strong group sales

The UK’s CBD market has flourished despite the impact of COVID-19. The rest of the world has steamed ahead with the legalisation of medical and recreational cannabis creating multibillion-dollar industries, while the UK has watched quietly

Cannabis affects everyone differently and can create deleterious effects for some individuals. One recent study indicates 30% of marijuana consumers have some degree of cannabis use disorder. These disorders are characterized by dependence. When a user experiences withdrawal

Anxiety relief is one of the main reasons why people become interested in CBD, and its anti-anxiety benefits have been well documented. There is, however, so much misinformation out there about CBD products, and it can

Reports estimate that up to 8 million people in the UK use CBD for its variety of wellness benefits. The market is currently worth £300 million, a figure which is expected to more than triple in

Sativa Group Plc [AQSE: SATI], the UK’s leading quoted CBD wellness and medicinal cannabis company, is launching a new Goodbody Wellness CBD and Vitamin D product range. The brand positioning has been strengthened with its increased

There may be over 34 million adult smokers in the US, but nearly 70% of those people are trying to kick the habit. Unfortunately, only a handful are ever successful, regardless if they try to quit

While more countries around the world continue to acknowledge the potential of CBD, the full biological effects of the cannabinoid are yet to be fully understood. However, some research demonstrates that CBD has anti-inflammatory and immunosuppressive

Sativa Group Plc [AQSE: SATI], the UK’s leading quoted CBD wellness and medicinal cannabis company, has recorded a record month of revenues for the Group in June. Record sales have been achieved in the month of

A new white paper has been published by leaders in the cannabis field, showcasing how to maximise clinical research and improve patient access to medical cannabis in the UK. Following the approval of medical cannabis in the

Hemp and CBD oil were federally legalized with the 2018 Farm Bill, but scientists have been researching cannabidiol and its potential benefits for many years prior to the cannabis boom. CBD products are gaining popularity at